Global Bio-pharma Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Publisher Name :
Date: 30-Dec-2019
No. of pages: 117
Inquire Before Buying

Summary

The global Bio-pharma market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025.

This report studies the Bio-pharma market size (value and volume) by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Bio-pharma in these regions, from 2014 to 2025, covering

- North America (United States, Canada and Mexico)

- Europe (Germany, UK, France, Italy, Russia and Turkey etc.)

- Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)

- South America (Brazil etc.)

- Middle East and Africa (Egypt and GCC Countries)

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in this market include

- Pfizer

- F. Hoffmann-La Roche AG

- Johnson & Johnson Services

- Sanofi, Amgen

- AbbVie

- Merck & Co., Inc

- Biogen Idec

- Bayer AG

- Eli Lilly and Company

- Novartis AG GlaxoSmithKline Plc

- Bristol-Myers Squibb Company

- AstraZeneca PLC

- Abbott Laboratories

By the product type, the market is primarily split into

- Monoclonal Antibodies

- Recombinant Proteins

- Granulocyte-Colony Stimulating Factor (G-CSF)

- Interferons

- Recombinant Human Insulin

- Erythropoietin

- Vaccines

- Growth Hormones

- Purified Proteins

- Others

By the end users/application, this report covers the following segments

- Metabolic Disorders

- Oncology

- Neurological Disorders

- Cardiovascular Diseases

- Inflammatory and Infectious Diseases

- Others

We can also provide the customized separate regional or country-level reports, for the following regions:

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Central & South America

- - Brazil

- Middle East & Africa

- - Turkey

- - GCC Countries

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Bio-pharma market size (value & volume) by company, key regions/countries, products and application, history data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Bio-pharma market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Bio-pharma manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

- To analyze the Bio-pharma with respect to individual growth trends, future prospects, and their contribution to the total market.

- To project the value and volume of Bio-pharma submarkets, with respect to key regions (along with their respective key countries).

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

- To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Bio-pharma are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million USD) and volume (K Pcs). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Bio-pharma market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Raw material suppliers

Distributors/traders/wholesalers/suppliers

Regulatory bodies, including government agencies and NGO

Commercial research & development (R&D) institutions

Importers and exporters

Government organizations, research organizations, and consulting firms

Trade associations and industry bodies

End-use industries

Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

Further breakdown of Bio-pharma market on basis of the key contributing countries.

Detailed analysis and profiling of additional market players.

Global Bio-pharma Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application

Table of Contents
1 Bio-pharma Market Overview
1.1 Bio-pharma Product Overview
1.2 Bio-pharma Market Segment by Type
1.2.1 Monoclonal Antibodies
1.2.2 Recombinant Proteins
1.2.3 Granulocyte-Colony Stimulating Factor (G-CSF)
1.2.4 Interferons
1.2.5 Recombinant Human Insulin
1.2.6 Erythropoietin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Purified Proteins
1.2.10 Others
1.3 Global Bio-pharma Market Size by Type
1.3.1 Global Bio-pharma Sales and Growth by Type
1.3.2 Global Bio-pharma Sales and Market Share by Type
1.3.3 Global Bio-pharma Revenue and Market Share by Type
1.3.4 Global Bio-pharma Price by Type
1.4 North America Bio-pharma by Type
1.5 Europe Bio-pharma by Type
1.6 South America Bio-pharma by Type
1.7 Middle East and Africa Bio-pharma by Type
2 Global Bio-pharma Market Competition by Company
2.1 Global Bio-pharma Sales and Market Share by Company (2014-2019)
2.2 Global Bio-pharma Revenue and Share by Company (2014-2019)
2.3 Global Bio-pharma Price by Company (2014-2019)
2.4 Global Top Players Bio-pharma Manufacturing Base Distribution, Sales Area, Product Types
2.5 Bio-pharma Market Competitive Situation and Trends
2.5.1 Bio-pharma Market Concentration Rate
2.5.2 Global Bio-pharma Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Bio-pharma Company Profiles and Sales Data
3.1 Pfizer
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Bio-pharma Product Category, Application and Specification
3.1.3 Pfizer Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 F. Hoffmann-La Roche AG
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Bio-pharma Product Category, Application and Specification
3.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Johnson & Johnson Services
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Bio-pharma Product Category, Application and Specification
3.3.3 Johnson & Johnson Services Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Sanofi, Amgen
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Bio-pharma Product Category, Application and Specification
3.4.3 Sanofi, Amgen Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 AbbVie
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Bio-pharma Product Category, Application and Specification
3.5.3 AbbVie Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Merck & Co., Inc
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Bio-pharma Product Category, Application and Specification
3.6.3 Merck & Co., Inc Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 Biogen Idec
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Bio-pharma Product Category, Application and Specification
3.7.3 Biogen Idec Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 Bayer AG
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Bio-pharma Product Category, Application and Specification
3.8.3 Bayer AG Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Eli Lilly and Company
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Bio-pharma Product Category, Application and Specification
3.9.3 Eli Lilly and Company Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Novartis AG GlaxoSmithKline Plc
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Bio-pharma Product Category, Application and Specification
3.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Bristol-Myers Squibb Company
3.12 AstraZeneca PLC
3.13 Abbott Laboratories
4 Bio-pharma Market Status and Outlook by Regions
4.1 Global Bio-pharma Market Status and Outlook by Regions
4.1.1 Global Bio-pharma Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Europe
4.1.4 Asia-Pacific
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Bio-pharma Sales and Revenue by Regions
4.2.1 Global Bio-pharma Sales Market Share by Regions (2014-2019)
4.2.2 Global Bio-pharma Revenue Market Share by Regions (2014-2019)
4.2.3 Global Bio-pharma Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Bio-pharma Sales, Revenue, Price and Gross Margin
4.3.1 North America Bio-pharma Sales by Countries
4.3.2 United States
4.3.3 Canada
4.3.4 Mexico
4.4 Europe Bio-pharma Sales, Revenue, Price and Gross Margin
4.4.1 Europe Bio-pharma Sales by Countries
4.4.2 Germany
4.4.3 France
4.4.4 UK
4.4.5 Italy
4.4.6 Russia
4.5 Asia-Pacific Bio-pharma Sales, Revenue, Price and Gross Margin
4.5.1 Asia-Pacific Bio-pharma Sales by Regions
4.5.2 China
4.5.3 Japan
4.5.4 South Korea
4.5.5 India
4.5.6 Australia
4.5.7 Indonesia
4.5.8 Thailand
4.5.9 Malaysia
4.5.10 Philippines
4.5.11 Vietnam
4.6 South America Bio-pharma Sales, Revenue, Price and Gross Margin
4.6.1 South America Bio-pharma Sales by Countries
4.6.2 Brazil
4.7 Middle East and Africa Bio-pharma Sales, Revenue, Price and Gross Margin
4.7.1 Middle East and Africa Bio-pharma Sales by Countries
4.7.2 Turkey
4.7.3 GCC Countries
4.7.4 Egypt
4.7.5 South Africa
5 Bio-pharma Application
5.1 Bio-pharma Segment by Application
5.1.1 Metabolic Disorders
5.1.2 Oncology
5.1.3 Neurological Disorders
5.1.4 Cardiovascular Diseases
5.1.5 Inflammatory and Infectious Diseases
5.1.6 Others
5.2 Global Bio-pharma Product Segment by Application
5.2.1 Global Bio-pharma Sales by Application
5.2.2 Global Bio-pharma Sales and Market Share by Application (2014-2019)
5.3 North America Bio-pharma by Application
5.4 Europe Bio-pharma by Application
5.5 Asia-Pacific Bio-pharma by Application
5.6 South America Bio-pharma by Application
5.7 Middle East and Africa Bio-pharma by Application
6 Global Bio-pharma Market Forecast
6.1 Global Bio-pharma Sales, Revenue Forecast (2019-2025)
6.1.1 Global Bio-pharma Sales and Growth Rate Forecast (2019-2025)
6.1.2 Global Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Bio-pharma Forecast by Regions
6.2.1 North America Bio-pharma Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Bio-pharma Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Bio-pharma Sales and Revenue Forecast (2019-2025)
6.2.4 South America Bio-pharma Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Bio-pharma Sales and Revenue Forecast (2019-2025)
6.3 Bio-pharma Forecast by Type
6.3.1 Global Bio-pharma Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Monoclonal Antibodies Growth Forecast
6.3.3 Recombinant Proteins Growth Forecast
6.4 Bio-pharma Forecast by Application
6.4.1 Global Bio-pharma Sales Forecast by Application (2019-2025)
6.4.2 Global Bio-pharma Forecast in Metabolic Disorders
6.4.3 Global Bio-pharma Forecast in Oncology
7 Bio-pharma Upstream Raw Materials
7.1 Bio-pharma Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Bio-pharma Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Sales Channel
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables and Figures
Figure Bio-pharma Product Picture
Figure Global Bio-pharma Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Bio-pharma Sales (K Pcs) Status and Outlook (2014-2025)
Figure Product Picture of Monoclonal Antibodies
Table Major Players of Monoclonal Antibodies
Figure Global Monoclonal Antibodies Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Recombinant Proteins
Table Major Players of Recombinant Proteins
Figure Global Recombinant Proteins Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Granulocyte-Colony Stimulating Factor (G-CSF)
Table Major Players of Granulocyte-Colony Stimulating Factor (G-CSF)
Figure Global Granulocyte-Colony Stimulating Factor (G-CSF) Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Interferons
Table Major Players of Interferons
Figure Global Interferons Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Recombinant Human Insulin
Table Major Players of Recombinant Human Insulin
Figure Global Recombinant Human Insulin Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Erythropoietin
Table Major Players of Erythropoietin
Figure Global Erythropoietin Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Vaccines
Table Major Players of Vaccines
Figure Global Vaccines Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Growth Hormones
Table Major Players of Growth Hormones
Figure Global Growth Hormones Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Purified Proteins
Table Major Players of Purified Proteins
Figure Global Purified Proteins Sales (K Pcs) and Growth Rate (2014-2019)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (2014-2019)
Table Global Bio-pharma Sales (K Pcs) and Growth Rate Comparison by Type (K Pcs)
Table Global Bio-pharma Sales (K Pcs) by Type (2014-2019) (K Pcs)
Table Global Bio-pharma Sales Share by Type (2014-2019)
Figure Global Bio-pharma Sales Market Share by Type (2014-2019)
Figure Global Bio-pharma Sales Market Share by Type in 2018
Table Global Bio-pharma Revenue (Million USD) by Type (2014-2019)
Table Global Bio-pharma Revenue Share by Type (2014-2019)
Figure Global Bio-pharma Revenue Share by Type (2014-2019)
Figure Global Bio-pharma Revenue Market Share by Type in 2018
Table Global Bio-pharma Price (USD/Pcs) by Type (2014-2019)
Table North America Bio-pharma Sales (USD/Pcs) by Type (2014-2019)
Figure North America Bio-pharma Sales Market Share by Type in 2018
Table Europe Bio-pharma Sales (USD/Pcs) by Type (2014-2019)
Figure Europe Bio-pharma Sales Market Share by Type in 2018
Table Asia-Pacific Bio-pharma Sales (USD/Pcs) by Type (2014-2019)
Figure Asia-Pacific Bio-pharma Sales Market Share by Type in 2018
Table South America Bio-pharma Sales (USD/Pcs) by Type (2014-2019)
Figure South America Bio-pharma Sales Market Share by Type in 2018
Table Middle East and Africa Bio-pharma Sales (USD/Pcs) by Type (2014-2019)
Figure Middle East and Africa Bio-pharma Sales Market Share by Type in 2018
Table Global Bio-pharma Sales (K Pcs) by Company (2014-2019)
Table Global Bio-pharma Sales Share by Company (2014-2019)
Figure Global Bio-pharma Sales Share by Company in 2018
Table Global Bio-pharma Revenue (Million US$) by Company (2014-2019)
Table Global Bio-pharma Revenue Share by Company (2014-2019)
Figure Global Bio-pharma Revenue Share by Company in 2018
Table Global Market Bio-pharma Average Price (USD/Pcs) by Company (2014-2019)
Table Global Bio-pharma Top Company Manufacturing Base Distribution and Sales Area
Table Global Bio-pharma Top Manufacturers Product Category
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) 15
Figure Global Bio-pharma Market Share of Top 5 Company
Figure Global Bio-pharma Market Share of Top 10 Company
Table Mergers & Acquisitions, Expansion Plans
Table Pfizer Basic Information List
Table Pfizer Bio-pharma Product Category, Application and Specification
Table Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Pfizer Description and Business Overview
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Bio-pharma Product Category, Application and Specification
Table F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure F. Hoffmann-La Roche AG Description and Business Overview
Table Johnson & Johnson Services Basic Information List
Table Johnson & Johnson Services Bio-pharma Product Category, Application and Specification
Table Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Johnson & Johnson Services Description and Business Overview
Table Sanofi, Amgen Basic Information List
Table Sanofi, Amgen Bio-pharma Product Category, Application and Specification
Table Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Sanofi, Amgen Description and Business Overview
Table AbbVie Basic Information List
Table AbbVie Bio-pharma Product Category, Application and Specification
Table AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure AbbVie Description and Business Overview
Table Merck & Co., Inc Basic Information List
Table Merck & Co., Inc Bio-pharma Product Category, Application and Specification
Table Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Merck & Co., Inc Description and Business Overview
Table Biogen Idec Basic Information List
Table Biogen Idec Bio-pharma Product Category, Application and Specification
Table Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Biogen Idec Description and Business Overview
Table Bayer AG Basic Information List
Table Bayer AG Bio-pharma Product Category, Application and Specification
Table Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Bayer AG Description and Business Overview
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Bio-pharma Product Category, Application and Specification
Table Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Eli Lilly and Company Description and Business Overview
Table Novartis AG GlaxoSmithKline Plc Basic Information List
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Product Category, Application and Specification
Table Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Novartis AG GlaxoSmithKline Plc Description and Business Overview
Table Bristol-Myers Squibb Company Basic Information List
Table AstraZeneca PLC Basic Information List
Table Abbott Laboratories Basic Information List
Table Global Bio-pharma Market Size Comparison by Regions (2014-2025) (K Pcs) & (Million US$)
Figure North America Bio-pharma Revenue (Million USD) and Growth Rate (2014-2025)
Figure Asia-Pacific Bio-pharma Revenue (Million USD) and Growth Rate (2014-2025)
Figure Europe Bio-pharma Revenue (Million USD) and Growth Rate (2014-2025)
Figure South America Bio-pharma Revenue (Million USD) and Growth Rate (2014-2025)
Figure Middle East and Africa Bio-pharma Revenue (Million USD) and Growth Rate (2014-2025)
Table Global Bio-pharma Sales (K Pcs) by Regions (2014-2019)
Table Global Bio-pharma Sales Market Share by Regions (2014-2019)
Figure Global Bio-pharma Sales Market Share by Regions (2014-2019)
Figure 2018 Global Bio-pharma Sales Market Share by Regions
Table Global Bio-pharma Revenue (Million USD) by Regions (2014-2019)
Table Global Bio-pharma Revenue Market Share by Regions (2014-2019)
Figure Global Bio-pharma Revenue Market Share by Regions (2014-2019)
Figure 2018 Global Bio-pharma Revenue Market Share by Regions
Table Global Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure North America Bio-pharma Sales Growth Rate
Table North America Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure United States Bio-pharma Sales (K Pcs)(2014-2019)
Figure United States Bio-pharma Revenue (Million USD)(2014-2019)
Figure Canada Bio-pharma Sales (K Pcs)(2014-2019)
Figure Canada Bio-pharma Revenue (Million USD)(2014-2019)
Figure Mexico Bio-pharma Sales (K Pcs)(2014-2019)
Figure Mexico Bio-pharma Revenue (Million USD)(2014-2019)
Figure Europe Bio-pharma Sales Growth Rate
Table Europe Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Germany Bio-pharma Sales (K Pcs)(2014-2019)
Figure Germany Bio-pharma Revenue (Million USD)(2014-2019)
Figure France Bio-pharma Sales (K Pcs)(2014-2019)
Figure France Bio-pharma Revenue (Million USD)(2014-2019)
Figure UK Bio-pharma Sales (K Pcs)(2014-2019)
Figure UK Bio-pharma Revenue (Million USD)(2014-2019)
Figure Italy Bio-pharma Sales (K Pcs)(2014-2019)
Figure Italy Bio-pharma Revenue (Million USD)(2014-2019)
Figure Russia Bio-pharma Sales (K Pcs)(2014-2019)
Figure Russia Bio-pharma Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Bio-pharma Sales Growth Rate
Table Asia-Pacific Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure China Bio-pharma Sales (K Pcs)(2014-2019)
Figure China Bio-pharma Revenue (Million USD)(2014-2019)
Figure Japan Bio-pharma Sales (K Pcs)(2014-2019)
Figure Japan Bio-pharma Revenue (Million USD)(2014-2019)
Figure South Korea Bio-pharma Sales (K Pcs)(2014-2019)
Figure South Korea Bio-pharma Revenue (Million USD)(2014-2019)
Figure India Bio-pharma Sales (K Pcs)(2014-2019)
Figure India Bio-pharma Revenue (Million USD)(2014-2019)
Figure Australia Bio-pharma Sales (K Pcs)(2014-2019)
Figure Australia Bio-pharma Revenue (Million USD)(2014-2019)
Figure Indonesia Bio-pharma Sales (K Pcs)(2014-2019)
Figure Indonesia Bio-pharma Revenue (Million USD)(2014-2019)
Figure Thailand Bio-pharma Sales (K Pcs)(2014-2019)
Figure Thailand Bio-pharma Revenue (Million USD)(2014-2019)
Figure Malaysia Bio-pharma Sales (K Pcs)(2014-2019)
Figure Malaysia Bio-pharma Revenue (Million USD)(2014-2019)
Figure Philippines Bio-pharma Sales (K Pcs)(2014-2019)
Figure Philippines Bio-pharma Revenue (Million USD)(2014-2019)
Figure Vietnam Bio-pharma Sales (K Pcs)(2014-2019)
Figure Vietnam Bio-pharma Revenue (Million USD)(2014-2019)
Figure South America Bio-pharma Sales Growth Rate
Table South America Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Brazil Bio-pharma Revenue (Million USD)(2014-2019)
Figure Brazil Bio-pharma Sales (K Pcs)(2014-2019)
Figure Middle East and Africa Bio-pharma Sales Growth Rate
Table Middle East and Africa Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2014-2019)
Figure Turkey Bio-pharma Sales (K Pcs)(2014-2019)
Figure Turkey Bio-pharma Revenue (Million USD)(2014-2019)
Figure GCC Countries Bio-pharma Sales (K Pcs)(2014-2019)
Figure GCC Countries Bio-pharma Revenue (Million USD)(2014-2019)
Figure Egypt Bio-pharma Sales (K Pcs)(2014-2019)
Figure Egypt Bio-pharma Revenue (Million USD)(2014-2019)
Figure South Africa Bio-pharma Sales (K Pcs)(2014-2019)
Figure South Africa Bio-pharma Revenue (Million USD)(2014-2019)
Figure Metabolic Disorders Examples
Figure Oncology Examples
Figure Neurological Disorders Examples
Figure Cardiovascular Diseases Examples
Figure Inflammatory and Infectious Diseases Examples
Figure Others Examples
Table Global Bio-pharma Sales (K Pcs) Comparison by Application (2014-2025)
Table Global Bio-pharma Sales (K Pcs) by Application (2014-2019)
Table Global Bio-pharma Sales Share by Application (2014-2019)
Figure Global Bio-pharma Sales Market Share by Application (2014-2019)
Figure Global Bio-pharma Sales Market Share by Application in 2018
Figure Global Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Global Bio-pharma Revenue (Million USD) and Growth Rate Forecast (2019-2025)
Table Global Bio-pharma Sales (K Pcs) Forecast by Regions (2019-2025)
Figure Global Bio-pharma Sales Market Share Forecast by Regions (2019-2025)
Figure North America Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure North America Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Europe Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Europe Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Asia-Pacific Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure China Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure China Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Japan Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Japan Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure South Korea Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure South Korea Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure India Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure India Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Australia Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Australia Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Indonesia Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Indonesia Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure South America Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure South America Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Middle East & Africa Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Turkey Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Turkey Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure GCC Countries Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure GCC Countries Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure Egypt Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure Egypt Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Figure South Africa Bio-pharma Sales (K Pcs) and Growth Rate Forecast (2019-2025)
Figure South Africa Bio-pharma Revenue and Growth Rate Forecast (2019-2025)
Table Global Bio-pharma Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Bio-pharma Sales Market Share Forecast by Type (2019-2025)
Table Global Bio-pharma Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Bio-pharma Revenue Market Share Forecast by Type (2019-2025)
Figure Monoclonal Antibodies Sales Growth Forecast
Figure Recombinant Proteins Sales Growth Forecast
Table Global Bio-pharma Sales (K Pcs) Forecast by Application (2019-2025)
Figure Global Bio-pharma Sales Forecast by Application (2019-2025)
Figure Global Bio-pharma Sales (K Pcs) Forecast in Metabolic Disorders
Figure Global Bio-pharma Sales (K Pcs) Forecast in Oncology
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Bio-pharma Manufacturing Cost Structure
Figure Bio-pharma Industrial Chain Analysis
Table Distributors List
Table Bio-pharma Downstream Customers
Table Research Programs/Design for This Report
Figure Data Triangulation
Figure Key Executives Interviewed
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Biopharmaceuticals Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 155
    According to our LPI (LP Information) latest study, the global Biopharmaceuticals market size was valued at US$ 31700 million in 2023. With growing demand in downstream market, the Biopharmaceuticals is forecast to a readjusted size of US$ 55380 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Biopharmaceuticals market. Biopharmaceuticals are expected to show stable growth in the future market. However, product di......
  • Global Bio-Pharma Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Bio-Pharma market: According to our latest research, the global Bio-Pharma market looks promising in the next 5 years. As of 2022, the global Bio-Pharma market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Bio-Pharma market, with a systematical de......
  • Global Bio-pharma Market Research Report 2023
    Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 91
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Bio-pharma market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Pfizer - F. Hoffmann-La Roche AG - Johnson & Johnson Services - Sanofi, Amgen - AbbVie - Merck & Co., Inc - Biogen Idec - Bayer AG - E......
  • Continuous Bioprocessing Market by Product (Chromatography, Filtration, Bioreactor, Media), Process (Upstream, Downstream), Scale of Operation (Commercial, Clinical), Application (mAbs, Vaccines, Cell & Gene Therapy), & End User - Global Forecast to 2028
    Published: 24-Nov-2023        Price: US 4950 Onwards        Pages: 273
    “Rising demand for biopharmaceuticals and growing adoption among CDMOs and CMOs are driving the growth of the continuous bioprocessing market.” The global continuous bioprocessing market is projected to reach USD 599 million by 2028 from USD 218 million in 2023, at a CAGR of 22.4% during the forecast period of 2023 to 2028. The growth of this market can be attributed to the increasing adoption of continuous bioprocessing among CDMOs and CMOs. Continuous b......
  • Global Biopharmaceuticals Professional Survey Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 3280 Onwards        Pages: 139
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • Global Biopharmaceuticals Market Research Report 2023, Forecast to 2028
    Published: 20-Nov-2023        Price: US 2680 Onwards        Pages: 160
    A biopharmaceutical, also known as a biologic medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of em......
  • 2023-2031 Report on Global Biopharmaceuticals Market by Player, Region, Type, Application and Sales Channel
    Published: 18-Sep-2023        Price: US 2500 Onwards        Pages: 85
    This report studies the Biopharmaceuticals market, covering market size for segment by type (Monoclonal Antibodies, Interferon, etc.), by application (Tumor, Diabetes, etc.), by sales channel (Direct Channel, Distribution Channel), by player (Roche, Amgen, Abbvie, Sanofi-Aventis, Johnson & Johnson, etc.) and by region (North America, Europe, Asia-Pacific, South America and Middle East & Africa). This report provides detailed historical analysis of global market for Biopharmaceutic......
  • Global Bio-pharma Market Insights, Forecast to 2029
    Published: 10-Aug-2023        Price: US 4900 Onwards        Pages: 108
    The global Bio-pharma market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The US & Canada market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Bio-pharma is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of......
  • Biopharmaceuticals Markets in China
    Published: 24-Jul-2023        Price: US 4000 Onwards        Pages: 233
    China's demand for Biopharmaceuticals has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, indu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs